Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,104,931 articles, preprints and more)

Suggested authors matching "AUTH:Isla D" with an ORCID

Dolores Isla
No affiliation detected
1
Publication
15,618
Citations
View profile

Search results

1-25 of 177 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2 3 Next ...

Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer.
Cheng Y, Spigel DR, Cho BC, Laktionov KK, Fang J, Chen Y, Zenke Y, Lee KH, Wang Q, Navarro A, Bernabe R, Buchmeier EL, Chang JW, Shiraishi Y, Goksu SS, Badzio A, Shi A, Daniel DB, Hoa NTT, [...] ADRIATIC Investigators
N Engl J Med, 391(14):1313-1327, 13 Sep 2024
Cited by: 2 articles | PMID: 39268857
Add to export list
Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study.
Ahn MJ, Tanaka K, Paz-Ares L, Cornelissen R, Girard N, Pons-Tostivint E, Vicente Baz D, Sugawara S, Cobo M, Pérol M, Mascaux C, Poddubskaya E, Kitazono S, Hayashi H, Hong MH, Felip E, Hall R, Juan-Vidal O, Brungs D, [...] TROPION-Lung01 Trial Investigators
J Clin Oncol, JCO2401544, 09 Sep 2024
Cited by: 1 article | PMID: 39250535
Add to export list
Peripheral Blood TCRβ Repertoire, IL15, IL2 and Soluble Ligands for NKG2D Activating Receptor Predict Efficacy of Immune Checkpoint Inhibitors in Lung Cancer.
Sesma A, Pardo J, Isla D, M Gálvez E, Gascón-Ruiz M, Martínez-Lostao L, Moratiel A, Paño-Pardo JR, Quílez E, Torres-Ramón I, Yubero A, Zapata-García M, Domingo MP, Esteban P, Sanz Pamplona R, Lastra R, Ramírez-Labrada A
Cancers (Basel), 16(16):2798, 08 Aug 2024
Cited by: 0 articles | PMID: 39199571 | PMCID: PMC11352724
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Expert Consensus on the Management of Adverse Events of Lorlatinib in the Treatment of ALK+ Advanced Non-small Cell Lung Cancer.
Arriola E, de Castro J, García-Campelo R, Bernárdez B, Bernabé R, Bruna J, Dómine M, Isla D, Juan-Vidal Ó, López-Fernández T, Nadal E, Rodríguez-Abreu D, Vares M, Asensio Ú, García LF, Felip E
Clin Drug Investig, 44(8):553-576, 31 Jul 2024
Cited by: 0 articles | PMID: 39085682 | PMCID: PMC11338981
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Impact of antibiotics, corticosteroids, and microbiota on immunotherapy efficacy in patients with non-small cell lung cancer.
Zapata-García M, Moratiel-Pellitero A, Isla D, Gálvez E, Gascón-Ruiz M, Sesma A, Barbero R, Galeano J, Del Campo R, Ocáriz M, Quílez E, Cruellas M, Remírez-Labrada A, Pardo J, Martínez-Lostao L, Domingo MP, Esteban P, Torres-Ramón I, Yubero A, [...] Lastra R
Heliyon, 10(13):e33684, 01 Jul 2024
Cited by: 0 articles | PMID: 39050456 | PMCID: PMC11268177
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Spatially Preserved Multi-Region Transcriptomic Subtyping and Biomarkers of Chemoimmunotherapy Outcome in Extensive-Stage Small Cell Lung Cancer.
Peressini M, Garcia-Campelo R, Massuti B, Martí C, Cobo M, Gutiérrez V, Dómine M, Fuentes J, Majem M, de Castro J, Córdoba JF, Diz MP, Isla D, Esteban E, Carcereny E, Vila L, Moreno-Vega A, Ros S, Moreno A, [...] Zugazagoitia J
Clin Cancer Res, 30(14):3036-3049, 01 Jul 2024
Cited by: 0 articles | PMID: 38630755
Add to export list
Amivantamab plus Lazertinib in Previously Untreated <i>EGFR</i>-Mutated Advanced NSCLC.
Cho BC, Lu S, Felip E, Spira AI, Girard N, Lee JS, Lee SH, Ostapenko Y, Danchaivijitr P, Liu B, Alip A, Korbenfeld E, Mourão Dias J, Besse B, Lee KH, Xiong H, How SH, Cheng Y, Chang GC, [...] MARIPOSA Investigators
N Engl J Med, 391(16):1486-1498, 26 Jun 2024
Cited by: 5 articles | PMID: 38924756
Add to export list
LACC Trial: Final Analysis on Overall Survival Comparing Open Versus Minimally Invasive Radical Hysterectomy for Early-Stage Cervical Cancer.
Ramirez PT, Robledo KP, Frumovitz M, Pareja R, Ribeiro R, Lopez A, Yan X, Isla D, Moretti R, Bernardini MQ, Gebski V, Asher R, Behan V, Coleman RL, Obermair A
J Clin Oncol, 42(23):2741-2746, 29 May 2024
Cited by: 2 articles | PMID: 38810208
Add to export list
The S-REAL study: Spanish real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy.
Gómez Rueda A, Taus Á, Álvarez Álvarez R, Bernabé-Caro R, Chara L, López-Brea M, Vilà L, Sala González MÁ, Del Barrio Díaz Aldagalán A, Esteban Herrera B, López Castro R, Álvarez Cabellos R, Doménech M, Falagan S, Moreno Vega A, Aguado C, Barba A, Delgado Ureña MT, Isla D, [...] Spanish Lung Cancer Group
Clin Transl Oncol, 26(7):1779-1789, 21 Mar 2024
Cited by: 0 articles | PMID: 38512450
Add to export list
Predictors of Immunotherapy Efficacy in Metastatic Non-Small Cell Lung Cancer: Lung Immune Prognostic Index and Immune-Related Toxicity.
Moratiel Pellitero A, Zapata Garcia M, Gascon Ruiz M, Arbones-Mainar JM, Lastra Del Prado R, Isla D
World J Oncol, 15(2):223-238, 21 Mar 2024
Cited by: 0 articles | PMID: 38545481 | PMCID: PMC10965262
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Biomarkers of Immunotherapy Response in Patients with Non-Small-Cell Lung Cancer: Microbiota Composition, Short-Chain Fatty Acids, and Intestinal Permeability.
Moratiel-Pellitero A, Zapata-García M, Gascón-Ruiz M, Sesma A, Quílez E, Ramirez-Labrada A, Martínez-Lostao L, Domingo MP, Esteban P, Yubero A, Barbero-Herranz R, Moreno-Blanco A, Paño JR, Lastra R, Pardo J, Isla D, Del Campo R, Gálvez E
Cancers (Basel), 16(6):1144, 13 Mar 2024
Cited by: 0 articles | PMID: 38539479 | PMCID: PMC10969216
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Association between missense variants of uncertain significance in the CHEK2 gene and hereditary breast cancer: a cosegregation and bioinformatics analysis.
Alonso N, Menao S, Lastra R, Arruebo M, Bueso MP, Pérez E, Murillo ML, Álvarez M, Alonso A, Rebollar S, Cruellas M, Arribas D, Ramos M, Isla D, Galano-Frutos JJ, García-Cebollada H, Sancho J, Andrés R
Front Genet, 14:1274108, 27 Feb 2024
Cited by: 0 articles | PMID: 38476463 | PMCID: PMC10927753
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Peripheral blood TCRβ repertoire, IL15, IL2 and soluble ligands for NKG2D activating receptor predict efficacy of ICI in lung cancer
Sesma A, Pardo J, Isla D, Gálvez EM, Gascón-Ruiz M, Martínez-Lostao L, Moratiel A, Paño-Pardo JR, Quílez E, Torres-Ramón I, Yubero A, Zapata-García M, Domingo MP, Esteban P, Lastra R, Ramírez-Labrada A, Pamplona RS
Research Square, 05 Mar 2024
Cited by: 0 articles | PPR: PPR814868
Add to export list Preprint v1
Impact of Antibiotics, Corticosteroids, and Microbiota on Immunotherapy Efficacy in Patients with Non-Small Cell Lung Cancer
Zapata-García M, Moratiel A, Isla D, Gálvez E, Gascón-Ruiz M, Sesma A, Barbero R, Galeano J, Campo Rd, Ocáriz M, Quílez E, Cruellas M, Remírez-Labrada A, Pardo J, Martínez-Lostao L, Domingo MP, Esteban P, Torres-Ramón I, Yubero A, [...] Lastra R
Research Square, 30 Jan 2024
Cited by: 0 articles | PPR: PPR794766
Add to export list Preprint v1
Detection of genomic alterations in liquid biopsies from patients with non-small cell lung cancer using FoundationOne Liquid CDx: a cost-effectiveness analysis.
Isla D, Álvarez R, Arnal M, Arriola E, Azkarate A, Azkona E, García-Campelo R, Garrido P, Nadal E, Ortega AL, Carcedo D, Crespo M, Lavara J, Córcoles F, Bernabé R
J Med Econ, 27(1):1379-1387, 01 Jan 2024
Cited by: 0 articles | PMID: 39387325
Add to export list
Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions.
Zhou C, Tang KJ, Cho BC, Liu B, Paz-Ares L, Cheng S, Kitazono S, Thiagarajan M, Goldman JW, Sabari JK, Sanborn RE, Mansfield AS, Hung JY, Boyer M, Popat S, Mourão Dias J, Felip E, Majem M, Gumus M, [...] PAPILLON Investigators
N Engl J Med, 389(22):2039-2051, 21 Oct 2023
Cited by: 39 articles | PMID: 37870976
Add to export list
MILACC study: could undetected lymph node micrometastases have impacted recurrence rate in the LACC trial?
Nitecki R, Ramirez PT, Dundr P, Nemejcova K, Ribeiro R, Vieira Gomes MT, Schmidt RL, Bedoya L, Isla DO, Pareja R, Rendón Pereira GJ, Lopez A, Kushner D, Cibula D
Int J Gynecol Cancer, 33(11):1684-1689, 06 Nov 2023
Cited by: 1 article | PMID: 37652529
Add to export list
PD-1/PD-L1 Inhibitors as Monotherapy in the First-Line Treatment of Advanced Non-Small Cell Lung Cancer Patients with High PD-L1 Expression: An Expert Position Statement.
Isla D, Sánchez A, Casal J, Cobo M, Majem M, Reguart N, Zugazagoitia J, Bernabé R
J Clin Med, 12(15):5063, 01 Aug 2023
Cited by: 1 article | PMID: 37568465 | PMCID: PMC10420126
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
The role of sex and gender in the diagnosis and treatment of lung cancer: the 6th ICAPEM Annual Symposium.
Viñolas N, Mezquita L, Corral J, Cobo M, Gil-Moncayo F, Paz-Ares L, Remon J, Rodríguez M, Ruano-Raviña A, Conde E, Majem M, Garrido P, Felip E, Isla D, de Castro J
Clin Transl Oncol, 26(2):352-362, 25 Jul 2023
Cited by: 0 articles | PMID: 37490262
Add to export list
[Risk factors for cancer-related cognitive impairment in breast and colorectal cancer patients who undergo chemotherapy].
Iranzo P, Callejo A, Arbej J, Menao S, Isla D, Andrés R
An Sist Sanit Navar, 46(2):e1040, 16 Aug 2023
Cited by: 0 articles | PMID: 37594060 | PMCID: PMC10498134
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Correction to: New update to the guidelines on testing predictive biomarkers in non‑small‑cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.
Isla D, Lozano MD, Paz-Ares L, Salas C, de Castro J, Conde E, Felip E, Gómez-Román J, Garrido P, Enguita AB
Clin Transl Oncol, 25(5):1488, 01 May 2023
Cited by: 0 articles | PMID: 36752960 | PMCID: PMC10119196
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
[New update to the guidelines on testing predictive biomarkers in non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology].
Isla D, Lozano MD, Paz-Ares L, Salas C, de Castro J, Conde E, Felip E, Gómez-Román J, Garrido P, Belén Enguita A
Rev Esp Patol, 56(2):97-112, 28 Mar 2023
Cited by: 2 articles | PMID: 37061248
Add to export list Review
A Subset of PD-1-Expressing CD56^bright NK Cells Identifies Patients with Good Response to Immune Checkpoint Inhibitors in Lung Cancer.
Gascón-Ruiz M, Ramírez-Labrada A, Lastra R, Martínez-Lostao L, Paño-Pardo JR, Sesma A, Zapata-García M, Moratiel A, Quílez E, Torres-Ramón I, Yubero A, Domingo MP, Esteban P, Gálvez EM, Pardo J, Isla D
Cancers (Basel), 15(2):329, 04 Jan 2023
Cited by: 10 articles | PMID: 36672279 | PMCID: PMC9856517
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Cost-effectiveness of atezolizumab versus pembrolizumab as first-line treatment in PD-L1-positive advanced non-small-cell lung cancer in Spain.
Isla D, Lopez-Brea M, Espinosa M, Arrabal N, Pérez-Parente D, Carcedo D, Bernabé-Caro R
Cost Eff Resour Alloc, 21(1):6, 16 Jan 2023
Cited by: 0 articles | PMID: 36647072 | PMCID: PMC9841669
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
New update to the guidelines on testing predictive biomarkers in non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.
Isla D, Lozano MD, Paz-Ares L, Salas C, de Castro J, Conde E, Felip E, Gómez-Román J, Garrido P, Enguita AB
Clin Transl Oncol, 25(5):1252-1267, 26 Dec 2022
Cited by: 5 articles | PMID: 36571695 | PMCID: PMC10119050
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC

1-25 of 177 results

1 2 3 Next ...

Search life-sciences literature (45,104,931 articles, preprints and more)

Suggested authors matching "AUTH:Isla D" with an ORCID

Search results

Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer.

Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study.

Peripheral Blood TCRβ Repertoire, IL15, IL2 and Soluble Ligands for NKG2D Activating Receptor Predict Efficacy of Immune Checkpoint Inhibitors in Lung Cancer.

Expert Consensus on the Management of Adverse Events of Lorlatinib in the Treatment of ALK+ Advanced Non-small Cell Lung Cancer.

Impact of antibiotics, corticosteroids, and microbiota on immunotherapy efficacy in patients with non-small cell lung cancer.

Spatially Preserved Multi-Region Transcriptomic Subtyping and Biomarkers of Chemoimmunotherapy Outcome in Extensive-Stage Small Cell Lung Cancer.

Amivantamab plus Lazertinib in Previously Untreated <i>EGFR</i>-Mutated Advanced NSCLC.

LACC Trial: Final Analysis on Overall Survival Comparing Open Versus Minimally Invasive Radical Hysterectomy for Early-Stage Cervical Cancer.

The S-REAL study: Spanish real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy.

Predictors of Immunotherapy Efficacy in Metastatic Non-Small Cell Lung Cancer: Lung Immune Prognostic Index and Immune-Related Toxicity.

Biomarkers of Immunotherapy Response in Patients with Non-Small-Cell Lung Cancer: Microbiota Composition, Short-Chain Fatty Acids, and Intestinal Permeability.

Association between missense variants of uncertain significance in the CHEK2 gene and hereditary breast cancer: a cosegregation and bioinformatics analysis.

Peripheral blood TCRβ repertoire, IL15, IL2 and soluble ligands for NKG2D activating receptor predict efficacy of ICI in lung cancer

Impact of Antibiotics, Corticosteroids, and Microbiota on Immunotherapy Efficacy in Patients with Non-Small Cell Lung Cancer

Detection of genomic alterations in liquid biopsies from patients with non-small cell lung cancer using FoundationOne Liquid CDx: a cost-effectiveness analysis.

Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions.

MILACC study: could undetected lymph node micrometastases have impacted recurrence rate in the LACC trial?

PD-1/PD-L1 Inhibitors as Monotherapy in the First-Line Treatment of Advanced Non-Small Cell Lung Cancer Patients with High PD-L1 Expression: An Expert Position Statement.

The role of sex and gender in the diagnosis and treatment of lung cancer: the 6th ICAPEM Annual Symposium.

[Risk factors for cancer-related cognitive impairment in breast and colorectal cancer patients who undergo chemotherapy].

Correction to: New update to the guidelines on testing predictive biomarkers in non‑small‑cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.

[New update to the guidelines on testing predictive biomarkers in non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology].

A Subset of PD-1-Expressing CD56^bright NK Cells Identifies Patients with Good Response to Immune Checkpoint Inhibitors in Lung Cancer.

Cost-effectiveness of atezolizumab versus pembrolizumab as first-line treatment in PD-L1-positive advanced non-small-cell lung cancer in Spain.

New update to the guidelines on testing predictive biomarkers in non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.

Partnerships & funding

Search life-sciences literature (45,104,931 articles, preprints and more)

Suggested authors matching "AUTH:Isla D" with an ORCID Suggested authors have linked their articles in Europe PMC to their ORCID iD. Up to two suggested authors with a matching surname and initial are shown, ordered by the total number of publications they have in Europe PMC.

Search results

Partnerships & funding

Suggested authors matching "AUTH:Isla D" with an ORCID